P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation

Detalles Bibliográficos
Autores principales: Schmetzer, H, Stankova, Z, Deen, D, Hirn, A, Vokac, Y, Kroell, T, Buhmann, R, Hausmann, A, Schmid, C, Tischer, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072431/
http://dx.doi.org/10.1186/2051-1426-2-S2-P10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072431/
http://dx.doi.org/10.1186/2051-1426-2-S2-P10

Ejemplares similares